Relapsed Diffuse Large B-Cell Lymphoma: Clinical Utility of Cell of Origin

被引：5
|
作者：
Vose, Julie M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
TISSUE MICROARRAY; GERMINAL CENTER; SURVIVAL; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; RITUXIMAB; SUBTYPES; IMPROVES;
D O I：
10.1200/JCO.2011.37.5733
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4065 / 4066
页数：2
相关论文
共 50 条
  • [1] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [2] Management of Relapsed Diffuse Large B-cell Lymphoma
    Crump, Michael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1195 - +
  • [3] Management of Relapsed Diffuse Large B-Cell Lymphoma
    Kenkre, Vaishalee Padgaonkar
    Smith, Sonali M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 393 - 403
  • [4] Management of relapsed diffuse large B-cell lymphoma
    Vaishalee Padgaonkar Kenkre
    Sonali M. Smith
    Current Oncology Reports, 2008, 10 : 393 - 403
  • [5] Cell of Origin Studies are not Always Concordant in Relapsed or Concurrent Biopsies of Diffuse Large B-cell Lymphoma
    Iqbal, Haaris
    Kroft, Steven
    Harrington, Alexandra
    Astle, John
    Cunningham, Ashley
    Leventaki, Vasiliki
    Hintzke, Maria
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1310 - 1311
  • [6] Cell of Origin Studies are not Always Concordant in Relapsed or Concurrent Biopsies of Diffuse Large B-cell Lymphoma
    Iqbal, Haaris
    Kroft, Steven
    Harrington, Alexandra
    Astle, John
    Cunningham, Ashley
    Leventaki, Vasiliki
    Hintzke, Maria
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1310 - 1311
  • [7] Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma
    Lu, Q.
    Huang, H.
    Tang, S.
    Wang, Y.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (09) : 571 - 580
  • [8] Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma
    Nijland, Marcel
    Seitz, Annika
    Terpstra, Martijn
    van Imhoff, Gustaaf W.
    Kluin, Philip M.
    van Meerten, Tom
    Atayar, Cigdem
    van Kempen, Leon C.
    Diepstra, Arjan
    Kok, Klaas
    van den Berg, Anke
    CANCERS, 2018, 10 (11):
  • [9] Neurolymphomatosis as a manifestation of relapsed diffuse large B-cell lymphoma
    Okamura-Shiki, Ikue
    Asakura, Koiku
    Ikeda, Takashi
    EJHAEM, 2022, 3 (04): : 1396 - 1397
  • [10] The Use of Glofitamab in Relapsed Diffuse Large B-Cell Lymphoma
    Falchi, Lorenzo
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01) : 12 - 15
12345